Cargando…
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function
The introduction of novel targeted therapies during the last 2 decades has led to a significant improvement in patients' clinical outcomes with renal cell carcinoma. However, this improvement came at the price of a whole new spectrum of adverse events, including renal toxicity. Systemic treatme...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110505/ https://www.ncbi.nlm.nih.gov/pubmed/33768301 http://dx.doi.org/10.1007/s00280-021-04260-y |